Pancreatic Cancer Research

ResearcherGuiyang Medical UniversityActive in the last 2 years

Yongning Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0912-4694; OpenAlex author ID A5017209474. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. ENO1-mediated deoxycytidine synthesis and gemcitabine resistance by stabilizing RRM2 in pancreatic cancer. Co-author DOI 10.1038/s41419-025-08061-6↗
  2. FAM126A interacted with ENO1 mediates proliferation and metastasis in pancreatic cancer via PI3K/AKT signaling pathway. Co-author DOI 10.1038/s41420-022-01047-9↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dijie Zheng · 1 shared paper, 2025 · strength 0.26
  2. Futang Li · 1 shared paper, 2025 · strength 0.26
  3. Zhiwei He · 1 shared paper, 2025 · strength 0.26
  4. Chao Yu · 1 shared paper, 2025 · strength 0.26
  5. Changhao Wu · 1 shared paper, 2025 · strength 0.26
  6. Peng Liu · 1 shared paper, 2022 · strength 0.17
  7. Songbai Liu · 1 shared paper, 2022 · strength 0.17
  8. Yaozhen Pan · 1 shared paper, 2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.